Form type | Sec Links | Description | Filing date | Reporting date |
---|---|---|---|---|
10-Q | Report | Data | 10-Q | Nov 14, 2024 | Sep 30, 2024 |
8-K | Report | Data | 8-K | Nov 14, 2024 | Nov 14, 2024 |
8-K | Report | Data | 8-K | Oct 8, 2024 | Oct 8, 2024 |
8-K | Report | Data | 8-K | Oct 4, 2024 | Oct 2, 2024 |
8-K | Report | Data | 8-K | Sep 27, 2024 | Sep 26, 2024 |
8-K | Report | Data | 8-K | Sep 3, 2024 | Aug 28, 2024 |
8-K | Report | Data | 8-K | Aug 16, 2024 | Aug 15, 2024 |
10-Q | Report | Data | 10-Q | Aug 14, 2024 | Jun 30, 2024 |
8-K | Report | Data | 8-K | Jul 25, 2024 | Jul 24, 2024 |
8-K | Report | Data | 8-K | Jun 7, 2024 | Jun 5, 2024 |
8-K | Report | Data | 8-K | May 9, 2024 | May 9, 2024 |
10-Q | Report | Data | 10-Q | May 9, 2024 | Mar 31, 2024 |
10-K | Report | Data | 10-K | Mar 28, 2024 | Dec 31, 2023 |
SC 13G | Report | CUEBIOPHARMA13G | Mar 11, 2024 | |
SC 13G | Report | Feb 7, 2024 | ||
SC 13G | Report | Jan 31, 2024 | ||
10-Q | Report | Data | 10-Q | Nov 3, 2023 | Sep 30, 2023 |
8-K | Report | Data | 8-K | Sep 14, 2023 | Sep 12, 2023 |
10-Q | Report | Data | 10-Q | Aug 8, 2023 | Jun 30, 2023 |
8-K | Report | Data | 8-K | Jun 9, 2023 | Jun 7, 2023 |
10-Q | Report | Data | 10-Q | May 9, 2023 | Mar 31, 2023 |
8-K | Report | Data | 8-K | Apr 25, 2023 | Apr 19, 2023 |
8-K | Report | Data | 8-K | Apr 12, 2023 | Apr 11, 2023 |
10-K | Report | Data | 10-K | Mar 21, 2023 | Dec 31, 2022 |
8-K | Report | Data | 8-K | Mar 10, 2023 | Mar 7, 2023 |
SC 13G | Report | CUE BIOPHARMA, INC. | Feb 14, 2023 | |
SC 13G/A | Report | Feb 3, 2023 | ||
SC 13G/A | Report | SC 13G/A | Dec 2, 2022 | |
SC 13G | Report | Nov 18, 2022 | ||
8-K | Report | Data | 8-K | Nov 15, 2022 | Nov 14, 2022 |
10-Q | Report | Data | 10-Q | Nov 14, 2022 | Sep 30, 2022 |
10-Q | Report | Data | 10-Q | Aug 4, 2022 | Jun 30, 2022 |
SC 13G | Report | Jul 8, 2022 | ||
8-K | Report | Data | 8-K | Jun 22, 2022 | Jun 16, 2022 |
8-K | Report | Data | 8-K | Jun 10, 2022 | Jun 9, 2022 |
10-Q | Report | Data | 10-Q | May 10, 2022 | Mar 31, 2022 |
8-K | Report | Data | 8-K | Mar 30, 2022 | Mar 28, 2022 |
10-K | Report | Data | 10-K | Mar 16, 2022 | Dec 31, 2021 |
8-K | Report | Data | 8-K | Feb 18, 2022 | Feb 15, 2022 |
SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
SC 13G | Report | Feb 10, 2022 | ||
SC 13G/A | Report | Feb 3, 2022 | ||
8-K | Report | Data | 8-K | Nov 15, 2021 | Nov 15, 2021 |
10-Q | Report | Data | 10-Q | Nov 9, 2021 | Sep 30, 2021 |
8-K | Report | Data | 8-K | Oct 1, 2021 | Oct 1, 2021 |
10-Q | Report | Data | 10-Q | Aug 9, 2021 | Jun 30, 2021 |
8-K | Report | Data | 8-K | Jun 14, 2021 | Jun 9, 2021 |
10-Q | Report | Data | 10-Q | May 10, 2021 | Mar 31, 2021 |
8-K | Report | Data | 8-K | Mar 18, 2021 | Mar 18, 2021 |
10-K | Report | Data | 10-K | Mar 9, 2021 | Dec 31, 2020 |
SC 13G | Report | SC 13G | Feb 16, 2021 | |
SC 13G/A | Report | SC 13G/A | Feb 12, 2021 | |
SC 13G/A | Report | CUE BIOPHARMA, INC. | Feb 12, 2021 | |
SC 13G/A | Report | Jan 29, 2021 | ||
8-K | Report | Data | 8-K | Nov 19, 2020 | Nov 18, 2020 |
10-Q | Report | Data | 10-Q Q3 2020 | Nov 9, 2020 | Sep 30, 2020 |
8-K | Report | Data | 8-K | Sep 17, 2020 | Sep 17, 2020 |
8-K | Report | Data | 8-K | Aug 24, 2020 | Aug 21, 2020 |
10-Q | Report | Data | 10-Q Q2 2020 CUE | Aug 7, 2020 | Jun 30, 2020 |
8-K | Report | 8-K | Jul 15, 2020 | Jul 9, 2020 |
8-K | Report | 8-K | Jun 26, 2020 | Jun 24, 2020 |
8-K | Report | 8-K | Jun 22, 2020 | Jun 22, 2020 |
8-K | Report | 8-K | Jun 5, 2020 | Jun 4, 2020 |
8-K | Report | 8-K | May 19, 2020 | May 19, 2020 |
10-Q | Report | Data | CUE-Q1-2020 | May 7, 2020 | Mar 31, 2020 |
10-K/A | Report | 10-K/A | Apr 29, 2020 | Dec 31, 2019 |
SC 13D/A | Report | Apr 21, 2020 | ||
8-K | Report | 8-K | Mar 27, 2020 | Mar 27, 2020 |
8-K | Report | 8-K | Mar 17, 2020 | Mar 17, 2020 |
10-K/A | Report | 10-K/A | Mar 12, 2020 | Dec 31, 2019 |
10-K | Report | Data | 10-K | Mar 12, 2020 | Dec 31, 2019 |
8-K | Report | 8-K | Mar 2, 2020 | Mar 2, 2020 |
SC 13G | Report | SC 13G | Feb 14, 2020 | |
SC 13G | Report | CUE BIOPHARMA, INC. | Feb 14, 2020 | |
8-K | Report | 8-K | Feb 10, 2020 | Feb 9, 2020 |
SC 13G | Report | Feb 7, 2020 | ||
SC 13D | Report | Dec 18, 2019 | ||
8-K | Report | 8-K | Nov 26, 2019 | Nov 22, 2019 |
8-K | Report | 8-K | Nov 12, 2019 | Nov 12, 2019 |
10-Q | Report | Data | 10-Q | Nov 7, 2019 | Sep 30, 2019 |
8-K | Report | 8-K | Oct 9, 2019 | Oct 3, 2019 |
8-K | Report | FORM 8-K | Oct 7, 2019 | Oct 3, 2019 |
10-Q | Report | Data | 10-Q | Aug 8, 2019 | Jun 30, 2019 |
8-K | Report | FORM 8-K | Aug 6, 2019 | Aug 6, 2019 |
10-Q/A | Report | 10-Q/A | Jul 9, 2019 | Mar 31, 2019 |
10-K/A | Report | AMENDMENT NO.2 TO FORM 10-K | Jul 9, 2019 | Dec 31, 2018 |
8-K | Report | 8-K | Jun 5, 2019 | Jun 5, 2019 |
10-Q | Report | Data | 10-Q | May 8, 2019 | Mar 31, 2019 |
10-K/A | Report | 10-K/A | Apr 30, 2019 | Dec 31, 2018 |
10-K | Report | Data | 10-K | Mar 14, 2019 | Dec 31, 2018 |
SC 13G/A | Report | SC 13G/A | Feb 14, 2019 | |
8-K/A | Report | 8-K/A | Dec 26, 2018 | Nov 6, 2018 |
8-K/A | Report | 8-K/A | Nov 13, 2018 | Nov 6, 2018 |
10-Q | Report | Data | 10-Q | Nov 13, 2018 | Sep 30, 2018 |
8-K | Report | 8-K | Nov 8, 2018 | Nov 6, 2018 |
10-Q | Report | Data | 10-Q | Aug 13, 2018 | Jun 30, 2018 |
8-K | Report | 8-K | Aug 3, 2018 | Jul 31, 2018 |
8-K | Report | FORM 8-K | Jul 12, 2018 | Jul 12, 2018 |
8-K | Report | FORM 8-K | Jun 26, 2018 | Jun 26, 2018 |
8-K | Report | FORM 8-K | Jun 25, 2018 | Jun 21, 2018 |
8-K | Report | FORM 8-K | Jun 20, 2018 | Jun 18, 2018 |
8-K | Report | FORM 8-K | Jun 12, 2018 | Jun 12, 2018 |
8-K | Report | 8-K | May 29, 2018 | May 25, 2018 |
8-K | Report | FORM 8-K | May 17, 2018 | May 17, 2018 |
10-Q | Report | Data | 10-Q | May 14, 2018 | Mar 31, 2018 |
8-K | Report | 8-K | Apr 30, 2018 | Apr 30, 2018 |
10-K | Report | FORM 10-K | Mar 29, 2018 | Dec 31, 2017 |
SC 13G | Report | SCHEDULE 13G | Feb 13, 2018 | |
8-K | Report | FORM 8-K | Jan 26, 2018 | Jan 22, 2018 |
SC 13G | Report | SC 13G | Jan 9, 2018 | |
8-K | Report | FORM 8-K | Dec 27, 2017 | Dec 27, 2017 |